SPINK1 and familial pancreatic carcinoma: C-di-AMP+Pg LPS treatment regulated five pathways not shown to be significantly regulated by other treatment groups, including SPINK1 pancreatic cancer pathway and cell cycle: G1/S checkpoint regulation pathway (Table S5).